Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Int J Biometeorol ; 64(6): 937-941, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31342241

ABSTRACT

Mud-bath therapy (MBT) has been used as a treatment for rheumatic diseases and musculoskeletal complaints in the Euganean Thermal Area (near Padova, Italy) since ancient time. There is no consensus about the use of MBT in patients with inflammatory rheumatic diseases, although experimental studies have suggested a beneficial effect of MBT on chronic articular inflammation. To evaluate the effects of MBT in patients affected by seronegative spondyloarthritis, very common chronic inflammatory rheumatic diseases, randomized controlled trials (RCT) performed in the Euganean Thermal Area have been reviewed. A significant improvement of spondylitis parameters was observed in enteropathic spondylitis, without bowel symptom exacerbation. A long-term amelioration of clinical evaluation indices was found in ankylosing spondylitis. A significant improvement of cutaneous lesions, arthritis activity, and patient's functional ability was observed in psoriatic arthritis. MBT was usually well tolerated and adverse side effects were rarely reported. The review of the RCT suggests that MBT may exert additional beneficial effects in patients with seronegative spondyloarthritis treated with pharmacological therapy.


Subject(s)
Mud Therapy , Rheumatic Diseases , Spondylarthritis , Spondylitis, Ankylosing , Humans , Italy , Randomized Controlled Trials as Topic
2.
Int J Biometeorol ; 62(12): 2065-2071, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30276474

ABSTRACT

Since ancient time, thermal baths and mudpacks have been used as treatments for rheumatic diseases and other musculoskeletal complaints. Despite basic researches suggest an anti-inflammatory effect of spa therapy, there is no consensus about the benefits of balneotherapy in patients with chronic inflammatory rheumatic diseases. The aim of this review is to summarize the currently available information on clinical effects of balneotherapy in these diseases. We did a literature search for articles considering the randomized controlled trials (RCTs) published until today. Although many selected studies do not have an elevated methodological quality, data from these RCTs support a beneficial effect of spa therapy. Balneotherapy highly improves the clinical course of the disease in patients with predominant axial involvement, such as with ankylosing and enteropathic spondylitis; the effects are less favorable in patients with predominant peripheral articular inflammation, such as rheumatoid arthritis. Good results have been observed in patients with psoriatic arthritis, but only few RCTs have been conducted on this disease. Spa therapy appears safe, and adverse events have been reported only in a few patients.


Subject(s)
Balneology , Rheumatic Diseases/therapy , Animals , Humans
4.
Joint Bone Spine ; 82(2): 104-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25623520

ABSTRACT

OBJECTIVES: Despite the efficacy of TNF inhibitors, most patients with psoriatic arthritis maintain a residual synovial inflammation. The main aim of the study was to evaluate the effects of mud-bath therapy on clinical picture of PsA patients treated with TNF inhibitors. The secondary outcome was to assess synovial inflammation in hand joints detected by contrast-enhanced ultrasound. Other aims were to verify the risk of arthritis flare and to evaluate the effects of spa treatment on functional ability and on quality of life. METHODS: Thirty-six patients with psoriatic arthritis, treated in the last 6 months with TNF inhibitors, were enrolled. After 1:1 randomisation, 18 patients (group A) underwent mud-bath therapy (12 mudpacks and 12 thermal baths), maintaining treatment with TNF inhibitors; 18 patients (group B) continued pharmacological therapy alone. CRP, PASI, DAS28, swollen and tender joint count, VAS pain, HAQ and SF-36 were evaluated at baseline (T0) and after 45 days (T1). Synovial inflammation detected by contrast-enhanced ultrasound, analysed by a software system, was also assessed. RESULTS: A significant improvement in PASI (P<0.005), DAS28 (P<0.05), swollen joint count and tender joint count (P<0.001), and HAQ (P<0.001) between T0 and T1 was observed in group A. No patient underwent a flare-up of arthritis. Ultrasound videos demonstrated a significant appearance delay (P<0.05) and faster washout (P<0.02) of contrast dye in group A patients with respect to group B. CONCLUSIONS: These data suggest a decrease of residual synovial inflammation and a beneficial clinical effect of spa therapy in psoriatic arthritis patients treated with TNF inhibitors.


Subject(s)
Arthritis, Psoriatic/diagnostic imaging , Arthritis, Psoriatic/therapy , Mud Therapy , Synovitis/diagnostic imaging , Synovitis/therapy , Adult , Aged , Anti-Inflammatory Agents/therapeutic use , Combined Modality Therapy , Contrast Media , Female , Hand Joints , Humans , Hyperthermia, Induced , Male , Middle Aged , Quality of Life , Treatment Outcome , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Ultrasonography
5.
J Med Imaging (Bellingham) ; 2(3): 034503, 2015 Jul.
Article in English | MEDLINE | ID: mdl-27014713

ABSTRACT

Inflammatory rheumatic diseases are the leading causes of disability and constitute a frequent medical disorder, leading to inability to work, high comorbidity, and increased mortality. The standard for diagnosing and differentiating arthritis is based on clinical examination, laboratory exams, and imaging findings, such as synovitis, bone edema, or joint erosions. Contrast-enhanced ultrasound (CEUS) examination of the small joints is emerging as a sensitive tool for assessing vascularization and disease activity. Quantitative assessment is mostly performed at the region of interest level, where the mean intensity curve is fitted with an exponential function. We showed that using a more physiologically motivated perfusion curve, and by estimating the kinetic parameters separately pixel by pixel, the quantitative information gathered is able to more effectively characterize the different perfusion patterns. In particular, we demonstrated that a random forest classifier based on pixelwise quantification of the kinetic contrast agent perfusion features can discriminate rheumatoid arthritis from different arthritis forms (psoriatic arthritis, spondyloarthritis, and arthritis in connective tissue disease) with an average accuracy of 97%. On the contrary, clinical evaluation (DAS28), semiquantitative CEUS assessment, serological markers, or region-based parameters do not allow such a high diagnostic accuracy.

6.
Med Eng Phys ; 35(2): 188-94, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22626639

ABSTRACT

Rheumatoid arthritis (RA) is a chronic multisystemic autoimmune disease, with an unclear etiopathogenesis. Its early diagnosis and activity assessment are essential to adjust the proper therapy. Among the different imaging techniques, ultrasonography (US) allows direct visualization of early inflammatory joint changes as synovitis, being also rapidly performed and easily accepted by patients. We propose an algorithm to semi-automatically detect synovial boundaries on US images, requiring minimal user interaction. In order to identify the synovia-bone and the synovia-soft tissues interfaces, and to tackle the morphological variability of diseased joints, a cascade of two different active contours is developed, whose composition corresponds to the whole synovial boundary. The algorithm was tested on US images acquired from proximal interphalangeal (PIP) and metacarpophalangeal (MCP) finger joints of 34 subjects. The results have been compared with a consensus manual segmentation. We obtained an overall mean sensitivity of 85±13%, and a mean Dice's similarity index of 80±8%, with a mean Hausdorff distance from the manual segmentation of 28±10 pixels (approximately 1.4±0.5mm), that are a better performance than those obtained by the raters with respect to the consensus.


Subject(s)
Image Processing, Computer-Assisted/methods , Synovial Membrane/diagnostic imaging , Ultrasonography/methods , Arthritis, Rheumatoid/diagnostic imaging , Humans , Male
7.
Rheumatol Int ; 33(1): 241-5, 2013 Jan.
Article in English | MEDLINE | ID: mdl-21947374

ABSTRACT

Despite advances in pharmacological therapy, physical treatment continues to be important in the management of ankylosing spondylitis (AS). The objective of the present study was to evaluate the effects and tolerability of combined spa therapy and rehabilitation in a group of AS patients being treated with TNF inhibitors. Thirty AS patients attending the Rheumatology Unit of the University of Padova being treated with TNF inhibitors for at least 3 months were randomized and assessed by an investigator independent from the spa staff: 15 were prescribed 10 sessions of spa therapy (mud packs and thermal baths) and rehabilitation (exercises in a thermal pool) and the other 15 were considered controls. The patients in both groups had been receiving anti-TNF agents for at least three months. The outcome measures utilized were BASFI, BASDAI, BASMI, VAS for back pain and HAQ. The evaluations were performed in all patients at the entry to the study, at the end of the spa treatment, and after 3 and 6 months. Most of the evaluation indices were significantly improved at the end of the spa treatment, as well as at the 3 and 6 months follow-up assessments. No significant alterations in the evaluation indices were found in the control group. Combined spa therapy and rehabilitation caused a clear, long-term clinical improvement in AS patients being treated with TNF inhibitors. Thermal treatment was found to be well tolerated and none of the patients had disease relapse.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Antirheumatic Agents/therapeutic use , Back Pain/therapy , Balneology , Exercise Therapy , Spondylitis, Ankylosing/rehabilitation , Adult , Aged , Back Pain/etiology , Back Pain/physiopathology , Combined Modality Therapy , Disability Evaluation , Etanercept , Female , Health Status , Humans , Immunoglobulin G/therapeutic use , Infliximab , Male , Middle Aged , Mud Therapy , Receptors, Tumor Necrosis Factor/therapeutic use , Recovery of Function , Severity of Illness Index , Spondylitis, Ankylosing/complications , Spondylitis, Ankylosing/physiopathology , Steam Bath , Treatment Outcome , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Young Adult
8.
J Clin Ultrasound ; 40(3): 147-54, 2012.
Article in English | MEDLINE | ID: mdl-22287501

ABSTRACT

PURPOSE.: To assess synovial microvascularity in finger joints with rheumatoid arthritis (RA) by contrast-enhanced ultrasound (CEUS), distinguishing between cases of active disease and those in remission; to standardize the technique for software analysis. METHODS.: Fifty-two finger joints of RA patients (26 with active disease and 26 in remission) were immersed in water and examined by CEUS using a fixed probe. Signal intensity curves were calculated with the software. RESULTS.: Contrast enhancement was detectable in all 26 patients with active RA (100%), but not in 25 of 26 patients in remission (96%); one of the latter patients (4%) showed minimal enhancement. The method's sensitivity and specificity in distinguishing active disease from remission were 100% and 96%. The grades of synovial enhancement correlated with clinical disease activity and software flow parameters. The peak contrast levels correlated with clinical activity, a peak of 9% representing the cutoff between remission and active disease. CONCLUSIONS.: CEUS with a fixed probe on finger joints immersed in water detected synovial vascularization in RA, producing results suitable for standardized software analysis and avoiding artifacts.


Subject(s)
Arthritis, Rheumatoid/diagnostic imaging , Contrast Media , Finger Joint/blood supply , Finger Joint/diagnostic imaging , Synovial Membrane/blood supply , Synovial Membrane/diagnostic imaging , Adult , Aged , Aged, 80 and over , Female , Humans , Image Enhancement/methods , Image Processing, Computer-Assisted/methods , Immersion , Male , Microbubbles , Middle Aged , Observer Variation , Phospholipids , Reproducibility of Results , Sensitivity and Specificity , Sulfur Hexafluoride , Ultrasonography/instrumentation , Water
9.
Rheumatol Int ; 32(5): 1219-23, 2012 May.
Article in English | MEDLINE | ID: mdl-21258796

ABSTRACT

Gastric involvement appears quite commonly in systemic sclerosis (SSc). The aim of this study was to evaluate gastric wall motility using ultrasonography, a noninvasive method able to track both filling and emptying of fundus and antrum. The study was performed in 20 SSc patients and 20 healthy control subjects. Gastric filling and emptying were evaluated by transabdominal ultrasonography, measuring changes in fundus and antral areas over a 1-h period after ingestion of a liquid bolus (500 ml of mineral water). Areas of both gastric fundus and antrum at basal evaluation were found to be smaller in SSc patients than in healthy controls. Gastric filling was significantly reduced after ingestion of liquid bolus. Gastric emptying was delayed both in fundus and antrum. No significant differences of gastric wall motility have been observed in different subsets of SSc patients. Our findings show that gastric dysmotility is frequent and severe in SSc patients, contributing to the gastrointestinal disturbances which are very common in this disease.


Subject(s)
Drinking , Gastric Fundus/diagnostic imaging , Gastrointestinal Motility , Gastroparesis/diagnostic imaging , Mineral Waters/administration & dosage , Pyloric Antrum/diagnostic imaging , Scleroderma, Systemic/complications , Adult , Aged , Case-Control Studies , Female , Gastric Emptying , Gastric Fundus/physiopathology , Gastroparesis/etiology , Gastroparesis/physiopathology , Humans , Italy , Male , Middle Aged , Predictive Value of Tests , Pyloric Antrum/physiopathology , Scleroderma, Systemic/diagnostic imaging , Scleroderma, Systemic/physiopathology , Time Factors , Ultrasonography
11.
Rheumatol Int ; 29(8): 891-5, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19050892

ABSTRACT

The sera of 39 patients (38 women and 1 man), 16 with limited and 23 with diffuse clinical form of systemic sclerosis (SSc), were tested for anti-centromere (ACA), anti-topoisomerase I (ATA) and anti-RNA polymerase III (ARA) antibodies. The presence of apoptotic cells in cultures of circulating lymphocytes was investigated using the TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling) technique. ACAs were present in 16 (41%), ATA in 15 (38%) and ARA in 8 (21%) cases. The mean frequency of apoptotic lymphocytes was statistically higher in the ARA positive patients with respect to that in the control population (P < 0.001), in ACA (P < 0.001) and in the ATA (P < 0.001) groups. Moreover, apoptosis was distributed homogenously in ACA and ATA positive subjects, but not in the ARA patients. Our results show that there is an increase in apoptosis in the lymphocytes of ARA positive SSc patients.


Subject(s)
Antibodies, Antinuclear/blood , Apoptosis/immunology , Lymphocytes/immunology , Scleroderma, Systemic/blood , Scleroderma, Systemic/immunology , Adult , Aged , Case-Control Studies , Cells, Cultured , Centromere/immunology , DNA Topoisomerases, Type I/immunology , Female , Humans , In Situ Nick-End Labeling , Male , Middle Aged , RNA Polymerase III/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...